Brief: China Medical System Announces License, Collaboration And Distribution Agreement For Zunveyl
Jan 8 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT WITH
ALPHA
COGNITION
* AGREEMENT FOR IMPROVED NEW DRUG ZUNVEYL FOR TREATMENT OF
MILD-TO-MODERATE DEMENTIA OF ALZHEIMER'S TYPE
* UNDER DEAL, GROUP TO HAVE EXCLUSIVE RIGHT TO DEVELOP,
OTHERS,
PRODUCT IN ASIA (EXCLUDING JAPAN), AUSTRALIA AND NEW ZEALAND
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says